SecBot SecBot
Insider Cluster (6 insiders) ·Filed Aug 27, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 4/10
Horizondays Processed2mo ago
Insider cluster: 6 insiders, $3.3M total
Actionable Insight • Neutral

The CEO's large sale is notable but not alarming given the small percentage of market cap and lack of amplifying context. Monitor for any subsequent Form 4 filings or 8-Ks that could provide a catalyst; if the selling continues at this pace, it may warrant a more bearish stance. For now, the cluster is routine and does not change the fundamental outlook.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$141.38
T+0 close · Aug 27, 2026 · via day close
Latest settled
+27.03%
T+20 · $179.60 · next T+60 in 7d
Vs SPY
+27.52%
α at T+20
Latest observation
−3.79%
T+54 · FF3 residual α
  1. T+0 · Aug 28 $141.38entry
  2. T+1 · 3mo ago −1.68%α −1.38% · $139.00
  3. T+5 · 2mo ago −11.78%α −11.89% · $124.72
  4. T+20 · 7w ago +27.03%α +27.52% · $179.60
  5. T+55 · todayOpen
  6. T+60 · in 7d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A cluster of insider selling at Twist Bioscience, led by CEO Emily Leproust selling ~$6.3M in open-market transactions on August 25, 2026, alongside the CAO, COO, CFO, and other executives selling a combined $3.27M over the prior week. The CEO's sales are large in absolute terms but represent a small fraction of the $10.2B market cap (~0.06%), and the cluster is likely driven by a shared blackout-window opening or 10b5-1 plan rather than a coordinated bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$3.3M
Insiders
6

Key Facts

  • CEO Emily Leproust sold 41,570 shares for ~$6.3M on August 25, 2026, at prices between $150.56 and $154.45.
  • Total cluster value is $3.27M across 6 insiders (CEO, CAO, COO, CFO, SVP HR, and another executive).
  • The cluster represents ~0.03% of Twist's $10.2B market cap, well below the 0.1% threshold for materiality.
  • No recent earnings, offering, restructuring, or late-filing cross-filings were found to amplify the signal.

Financial Impact

Total insider sales of $3.27M, or ~0.03% of market cap, are trivial relative to company size.

insider ownershipdilution

Risk Factors

  • CEO selling $6.3M in a single day could be a liquidity event (e.g., tax planning, diversification) but may also signal peak valuation concerns.
  • If the company announces an offering or disappointing earnings in the next 30 days, the insider sales could be viewed as informed selling in hindsight.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1787900973069

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 28, 2026